Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglubulinemia

Autor: José Ignacio Fortea Ormaechea, Mar Lozano Maya, Luisa Adán Merino, José Barrio Antoranz, Sonia Martín Chavarri, Elena Corchete Prats, Eva Martínez Acebes, Mercedes Aldeguer Martínez

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 105, Iss 8, Pp 490-493 (2013)

Mixed cryoglobulinemia (MC) is a small-vessel systemic vasculitis characterized by the presence of cryoglobulins, immunoglobulin complexes that precipitate at low temperatures (< 37 ºC) inducing the inflammatory process. The most frequent etiology i

Externí odkaz: https://doaj.org/article/f74393072e52450199bbdca7345b01db

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

Autor: J L Pérez-Calle, Yago González-Lama, Ángel Ponferrada, María Isabel Vera, R. Pajares, B. Casis, María Chaparro, Pilar Martinez Montiel, Luis Menchén, José Ignacio Fortea-Ormaechea, L. Abreu, Antonio Roman, Javier P. Gisbert, Ignacio Marín-Jiménez, Pilar López Serrano, Fernando Bermejo, Manuel Van Domselaar

Publikováno v: Gastroenterología y Hepatología. 34:443-448

To evaluate effectiveness and safety of adalimumab in CD patients of the Madrid area and identify predictors of response.Multicenter retrospective survey of all CD patients treated with adalimumab in 9 hospitals of the Madrid area (Spain). Univariate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d4d44b60e31251adb5bb781ac95acec
https://doi.org/10.1016/j.gastrohep.2011.04.001

[Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease]

Autor: José Ignacio Fortea, Ormaechea, Javier P, Gisbert, Ignacio, Marín-Jiménez

Publikováno v: Gastroenterologia y hepatologia. 32(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d80ae549af51694b41487c67ea637bb1
https://pubmed.ncbi.nlm.nih.gov/19457586

Congestive Hepatopathy.

Autor: Fortea, José Ignacio^1,2,3 (AUTHOR) angelapuente@hotmail.com, Puente, Ángela^1,2,3 (AUTHOR) antonio.cuadrado@scsalud.es, Cuadrado, Antonio^1,2,3 (AUTHOR) patricia.huelin@scsalud.es, Huelin, Patricia^1,2,3 (AUTHOR) ines.garciac@scsalud.es, Pellón, Raúl⁴ (AUTHOR) raul.pellon@scsalud.es, González Sánchez, Francisco José⁴ (AUTHOR) franciscojose.gonzalezs@scsalud.es, Mayorga, Marta⁵ (AUTHOR) martam.mayorga@scsalud.es, Cagigal, María Luisa⁵ (AUTHOR) mluisa.cagigal@scsalud.es, García Carrera, Inés¹ (AUTHOR) marina.cobrerosdel@scsalud.es, Cobreros, Marina¹ (AUTHOR) javiercrespo1991@gmail.com, Crespo, Javier^1,2,3 (AUTHOR) emilio.fabrega@scsalud.es, Fábrega, Emilio^1,2,3 (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Dec2020, Vol. 21 Issue 24, p9420. 1p.

Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain

Autor: Javier Crespo, María Luisa Cagigal Cobo, Carmen Álvarez Tato, Paloma Álvarez Fernández, Roberto Fernández Santiago, Angela Puente, Jorge Calvo Montes, Emilio Fábrega, Inés García Carrera, Patricia Huelin, Juan Andrés Echeverri Cifuentes, Fernando Casafont, Antonio Cuadrado, Marina Cobreros, José Ignacio Fortea, Carlos Ruiz de Alegría Puig, Federico José Castillo Suescun, Juan Carlos Rodríguez Sanjuán

Publikováno v: Journal of Clinical Medicine, Vol 9, Iss 3573, p 3573 (2020)
J Clin Med . 2020 Nov 6;9(11):3573
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Journal of Clinical Medicine
Volume 9
Issue 11

In liver transplant (LT) recipients, Pneumocystis jirovecii pneumonia (PJP) is most frequently reported before 1992 when immunosuppressive regimens were more intense. It is uncertain whether universal PJP prophylaxis is still applicable in the contem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1628d8db49a8cc4e5957a6373264594c
https://doi.org/10.3390/jcm9113573